CSIMEMPHIS: Long-term Follow-up of Medulloblastoma Survivors That Received Craniospinal Irradiation

Abroad (travel likely)Recruiting

Conditions

Medulloblastoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Contact: Study coordinator (Thomas E. Merchant, DO, PhD) · referralinfo@stjude.org · 888-226-4343

Study leads

Thomas E Merchant, DO, PhD
Principal Investigator
St. Jude Children's Research Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

High Grade Glioma · Meningioma · Embryonal Tumor

Abroad (travel likely)RecruitingPHASE1, PHASE2

Aurora, United States · Cincinnati, United States

A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

Childhood Medulloblastoma

Abroad (travel likely)RecruitingPHASE3

Birmingham, United States · Mobile, United States

Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation

CNS Embryonal Tumor · CNS, Medulloblastoma · Atypical Teratoid Rhabdoid Tumor

Abroad (travel likely)RecruitingEARLY_PHASE1

Calgary, Canada · Vancouver, Canada

A Study of 177Lu-DTPA-Omburtamab in Children and Adolescents With Brain Cancer or Cancer That Has Spread to the Central Nervous System (CNS)

Recurrent Medulloblastoma · Refractory Medulloblastoma · CNS Metastases

Abroad (travel likely)RecruitingPHASE1

Basking Ridge, United States · Middletown, United States